Home › Syn X Pharma › John Marshall

JM

John Marshall — 66 Patents

SPSyn X Pharma: 26 patents #2 of 11Top 20%

GEGenzyme: 17 patents #22 of 891Top 3%

NANanogen: 9 patents #9 of 86Top 15%

BUBrown University: 4 patents #33 of 478Top 7%

TIThe University Of Iowa: 1 patents #4 of 47Top 9%

UNUnknown: 1 patents #29,356 of 83,584Top 40%

Chicago, IL: #78 of 13,327 inventorsTop 1%

Illinois: #462 of 84,256 inventorsTop 1%

Overall (All Time): #32,599 of 4,157,543Top 1%

66 Patents All Time

John Marshall has been granted 66 US patents while listed as an inventor at Syn X Pharma. The first was granted in 1997 and the most recent in March 2025. John Marshall ranks #32,599 of 4,157,543 US inventors in our database (top 0.78%). Patent records list John Marshall in Chicago, IL, US.

Patents per Year

Issued Patents All Time

Showing 1–25 of 66 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
12257292	Enhanced delivery of antioxidants for treatment of central nervous system disorders involving oxidative stress	Ryan Kole, Meriel Owen	2025-03-25
12240920	Cyclic peptidomimetic for the treatment of neurological disorders	—	2025-03-04
12060349	Glucosylceramide synthase inhibitors	Elyse Bourque, Mario CABRERA-SALAZAR, Cassandra Celatka, Seng H. Cheng, Bradford H. Hirth +12 more	2024-08-13
11879020	Cyclic peptidomimetic for the treatment of neurological disorders	—	2024-01-23
11612642	Enhanced delivery of antioxidants for treatment of central nervous system disorders involving oxidative stress	Ryan Kole, Meriel Owen	2023-03-28
11498018	Extraction and purification of cannabinoid compounds	Lesley G. Campbell	2022-11-15
11008316	Glucosylceramide synthase inhibitors	Elyse Bourque, Mario CABRERA-SALAZAR, Cassandra Celatka, Seng H. Cheng, Bradford H. Hirth +12 more	2021-05-18
10046024	Cyclic-GluR6 analogs, methods of treatment and use	Mark Spaller, Dennis J. Goebel	2018-08-14
10040822	Neuroprotective composition and method of use	Dennis J. Goebel	2018-08-07
9964538	Methods and compositions for enzyme linked immuno and hybridization mass spectrometric assay	Angelica Kirsten Florentinus	2018-05-08
9403876	Cyclic-GluR6 analogs, methods of treatment and use	Mark Spaller, Dennis J. Goebel	2016-08-02
8673857	Long term potentiation with cyclic-GluR6 analogs	Andrew Peter Mallon	2014-03-18
7329501	Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance	George Jackowski	2008-02-12	$599,000
7314762	Apolipoprotein biopolymer markers indicative of insulin resistance	George Jackowski	2008-01-01
7314717	Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons	George Jackowski, Brad Thatcher, Jason Yantha, Tammy Vrees	2008-01-01
7294688	Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons	George Jackowski, Brad Thatcher, Jason Yantha, Tammy Vrees	2007-11-13	$830,000
7229638	Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons	George Jackowski, Brad Thatcher, Jason Yantha, Tammy Vrees	2007-06-12
7179606	IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease	George Jackowski	2007-02-20
7179605	Fibronectin precursor biopolymer markers indicative of alzheimer's disease	George Jackowski	2007-02-20	$645,000
7179610	Complement C3 precursor biopolymer markers indicative of insulin resistance	George Jackowski	2007-02-20	$645,000
7135297	Protein biopolymer markers indicative of insulin resistance	George Jackowski	2006-11-14	$818,000
7132244	Betaine/GABA transport protein biopolymer marker indicative of insulin resistance	George Jackowski	2006-11-07
7125678	Protein biopolymer markers predictive of type II diabetes	George Jackowski	2006-10-24	$1,757,000
7125726	Method and kit for diagnosing myocardial infarction	George Jackowski, Brad Thatcher, Jason Yantha, Tammy Vrees	2006-10-24
7122327	Biopolymer markers indicative of type II diabetes	George Jackowski	2006-10-17	$1,728,000